Evidence map›Paper›PMID 31452173›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2020

Two- and Three-Dimensional Bioengineered Human Intestinal Tissue Models for Cryptosporidium.

Daviel Cardenas, Seema Bhalchandra, Hymlaire Lamisere, Ying Chen, Xi-Lei Zeng, Sasirekha Ramani, Umesh C Karandikar, David L Kaplan, Mary K Estes, Honorine D Ward

Abstract read
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Review
  2. Apical-out bovine intestinal organoids as an infection model forCurrent research in parasitology & vector-borne diseases · 2025
    Article
  3. Rapid review: Recent advances inCurrent research in parasitology & vector-borne diseases · 2025
    Review
  4. Article
  5. Addressing Key Questions in Organoid Models: Who, Where, How, and Why?International journal of molecular sciences · 2023
    Review
  6. ExploringFrontiers in cellular and infection microbiology · 2023
    Review
  7. Article
  8. Article
  9. Article
  10. Current clinical microbiology reports · 2021
    Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Analysis of Long Non-Coding RNA inFrontiers in cellular and infection microbiology · 2020
    Article
  17. Gut microbes
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Daviel CardenasTufts Medical Center, Boston, MA, USA.
Seema BhalchandraTufts Medical Center, Boston, MA, USA.
Hymlaire LamisereTufts University Sackler School of Graduate Biomedical Sciences, Boston, MA, USA.
Ying ChenTufts University School of Engineering, Medford, MA, USA.
Xi-Lei ZengBaylor College of Medicine, Houston, TX, USA.
Sasirekha RamaniBaylor College of Medicine, Houston, TX, USA.
Umesh C KarandikarBaylor College of Medicine, Houston, TX, USA.
David L KaplanTufts University Sackler School of Graduate Biomedical Sciences, Boston, MA, USA.
Mary K EstesBaylor College of Medicine, Houston, TX, USA.
Honorine D WardTufts Medical Center, Boston, MA, USA. hward@tuftsmedicalcenter.org.

Funding

Tissue Analysis & Molecular Imaging CoreP30DK056338 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI Geoffrey A Preidis · 2001 to 2026
$28.3M
Novel Platforms for Human Intestinal Enteroids: Matrix, Mechanics, and TopographyU19AI116497 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI PIEDRA, PEDRO A · 2015 to 2025
$13.2M
Interaction of enteropathogenic Yersinia and Vibrio cholera with engineered human intestinal tissueU19AI131126 · NIAID · TUFTS UNIVERSITY BOSTON · PI ISBERG, RALPH R., KAPLAN, DAVID L. · 2017 to 2021
$8.1M
Tufts-CMC Framework Program for Global Health InnovationD43TW009377 · FIC · TUFTS UNIVERSITY BOSTON · PI KANG, GAGANDEEP, WANKE, CHRISTINE A · 2013 to 2017
$1.6M
A bioengineered 3D primary human intestinal model for CryptosporidiumR21AI128342 · NIAID · TUFTS MEDICAL CENTER · PI KAPLAN, DAVID L., WARD, HONORINE D · 2017 to 2018
$474k
An Ex Vivo 3-D Pre-Clinical Human Enteroid Model for CryptosporidiumR21AI120932 · NIAID · TUFTS MEDICAL CENTER · PI WARD, HONORINE D · 2015 to 2016
$454k
FIC NIH HHS D43 TW009377NIAID NIH HHS R21 AI120932NIAID NIH HHS R21 AI128342NIAID NIH HHS U19 AI116497NIAID NIH HHS U19 AI131126NIDDK NIH HHS P30 DK056338
6 · The paper itself

Abstract

Conventional cell cultures utilizing transformed or immortalized cell lines or primary human epithelial cells have played a fundamental role in furthering our understanding of Cryptosporidium infection. However, they remain inadequate with respect to their inability to emulate in vivo conditions, support long-term growth, and complete the life cycle of the parasite. Previously, we developed a 3D silk scaffold-based model using transformed human intestinal epithelial cells (IECs). This model supported C. parvum infection for up to 2 weeks and resulted in completion of the life cycle of the parasite. However, transformed IECs are not representative of primary human IEC.Human intestinal enteroids (HIEs) are cultures derived from crypts that contain Lgr5

Indexed as

OrganoidsCell Culture TechniquesCell LineCells, CulturedCoculture TechniquesCryptosporidiumEpithelial CellsHumansIntestinal MucosaMicroscopy, Electron, ScanningMyofibroblastsOocystsReceptors, G-Protein-CoupledSporozoitesStem CellsTissue EngineeringLGR5 protein, humanReceptors, G-Protein-CoupledDrug screenEnteroidIntestinalMonolayerOrganoidPermeable supportSilk scaffoldStem cellThree dimensionalTissueTranswell

Identifiers

PMID31452173
PMCPMC7058245

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.